Following up on the last post, Dr. Mike Lawlor sent me this in an email:
"Audentes
Therapeutics officially announced the dosing of the first patient for the
X-linked myotubular myopathy treatment trial that we’ve been working on over
the past few years. We’ve been very involved in the translation from dogs
to humans, and will be doing the human pathology work for the trial.
Here’s a link to that press release."
I discuss issues pertaining to the practice of neuropathology -- including nervous system tumors, neuroanatomy, neurodegenerative disease, muscle and nerve disorders, ophthalmologic pathology, neuro trivia, neuropathology gossip, job listings and anything else that might be of interest to a blue-collar neuropathologist.
Subscribe to:
Post Comments (Atom)
Neuropathology Blog is Signing Off
Neuropathology Blog has run its course. It's been a fantastic experience authoring this blog over many years. The blog has been a source...
-
Shannon Curran, MS with her dissection Shannon Curran, a graduate student in the Modern Human Anatomy Program at the University of Co...
-
Last summer I put up a post about a remarkable whole nervous system dissection that was carried out at the University of Colorado School of ...
No comments:
Post a Comment